¹Ù·Î°¡±â ¸Þ´º

¹Ù·Î°¡±â ¸Þ´º º»¹®³»¿ë ¹Ù·Î°¡±â ¸ÞÀθ޴º ¹Ù·Î°¡±â

ÁÖ¿ä¾È³»

HOME »çÀÌÆ®¸Ê

FONT SIZE

ÆùƮũ±â Å°¿ò 100% 110% 120% 130% 140% ÆùƮũ±â ÁÙÀÓ
¸Þ´ºº¸±â
 
Á¦¸ñ
2/22 ¹ßÇ¥³í¹® ÀÔ´Ï´Ù
ÀÛ¼ºÀÏ
2020-02-20
Á¶È¸¼ö
306


¾È³çÇϼ¼¿ä 

À̹ø ÁÖ Àú³Î¹ßÇ¥¸¦ ¸ÃÀº ±¸¹ÎÁ¤ÀÔ´Ï´Ù.
±×°£ Á¦°¡ ¿¬±¸ÁÖÁ¦·Î ´Ù·ç°í ÀÖ´Â gammadelta T cell¿¡ ´ëÇÑ ³í¹®À» ¸¹ÀÌ ¹ßÇ¥ Çß¾ú´Âµ¥,

À̹ø¿¡´Â intestinal bowel disease (IBD) ¿¬±¸ ¸ðµ¨ Áß ÇϳªÀÎ DSS colitis ¸ðµ¨°ú °ü·ÃÇÑ ³í¹®À» ¹ßÇ¥ÇÏ°íÀÚ ÇÕ´Ï´Ù.
oxysterol ¹× DSS colitis¿¡ ´ëÇÑ °øºÎ¸¦ Çϸ鼭 ¾Ë°ÔµÈ ³í¹®À¸·Î,
intestinal lymphoid structure Çü¼º°ú °ü·ÃµÇ´Â oxysterol°ú Àå ¿°Áõ°úÀÇ °ü·Ã¼ºÀ» º¸¿©ÁÖ°í ÀÖ´Â ³í¹®ÀÔ´Ï´Ù. 

½ÅÁ¾Äڷγª ¹ÙÀÌ·¯½º°¡ ¿©ÀüÈ÷ ¸¸¿¬ÇØ ÀÖ´Â »óȲÀε¥, ´Ùµé °Ç°­ Àß Ã¬±â½Ã±æ ¹Ù¶ø´Ï´Ù.
Åä¿äÀÏ¿¡ ºË°Ú½À´Ï´Ù.


Mucosal Immunology 2019
The EBI2-oxysterol axis promotes the development of intestinal lymphoid structures and colitis

https://www.nature.com/articles/s41385-019-0140-x


±¸¹ÎÁ¤ ¿Ã¸²
÷ºÎÆÄÀÏ:
÷ºÎÆÄÀÏÀÌ ¾ø½À´Ï´Ù.
´ÙÀ½±Û
2/22 ¹ßÇ¥³í¹®ÀÔ´Ï´Ù.
/ ±è³ª·¡
¾È³çÇϼ¼¿ä À̹øÁÖ Àú³Î ¹ßÇ¥¸¦ ¸Ã°ÔµÈ ³ª·¡ÀÔ´Ï´Ù. Á¦°¡ À̹øÁÖ ¹ßÇ¥ÇÏ°ÔµÉ ³í¹®Àº Cancer Research (IF:9.130) ¿¡ 2016³â °ÔÀçµÈ ³í¹®À¸·Î Tumor micronvironment¿¡¼­ M-CSF¿Í GM-CSF receptor signalingÀÌ monocyteÀÇ maturation°ú macrophage polarization¿¡ ¾î¶°ÇÑ ¿µÇâÀ» ¹ÌÄ¡´ÂÁö¿¡ °üÇØ ¼Ò°³ÇÏ°íÀÖ½À´Ï´Ù...
ÀÌÀü±Û
2/8 ¹ßÇ¥³í¹®ÀÔ´Ï´Ù.
/ ±èö±Õ
À̹ø¿¡ ¹ßÇ¥ÇÒ ³í¹®ÀÇ Á¦¸ñÀº Naringenin Enhances the Antitumor Effect of Therapeutic Vaccines by Promoting Antigen Cross-Presentation À̸ç Áö³­ÇØ 12¿ù¿¡ Jounal of immunology ¿¡ ÃâÆǵǾú½À´Ï´Ù. ½Ä¹° À¯·¡ÀÇ metaboliteÀÇ ÇÑ Á¾·ùÀÎ FlavonoidsÀÎ NaringeninÀ̶ó´Â ¹°ÁúÀÌ Ç׿øÀÇ cross-presentationÀ» Çâ»ó..